MiMedx Group, Inc. Given Average Recommendation of Buy by Brokerages
MDXG Stock | USD 8.85 0.05 0.57% |
Roughly 53% of MiMedx's stockholders are presently thinking to get in. The analysis of the overall investor sentiment regarding MiMedx Group suggests that some traders are interested. The current market sentiment, together with MiMedx's historical and current headlines, can help investors time the market. In addition, many technical investors use MiMedx Group stock news signals to limit their universe of possible portfolio assets.
MiMedx |
Shares of MiMedx Group, Inc. have been assigned an average recommendation of Buy from the five brokerages that are currently covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have issued a report on the
Read at thelincolnianonline.com
MiMedx Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards MiMedx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
MiMedx Fundamental Analysis
We analyze MiMedx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MiMedx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MiMedx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
MiMedx is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
MiMedx Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MiMedx stock to make a market-neutral strategy. Peer analysis of MiMedx could also be used in its relative valuation, which is a method of valuing MiMedx by comparing valuation metrics with similar companies.
Peers
MiMedx Related Equities
ERAS | Erasca | 3.00 | ||||
IPSC | Century Therapeutics | 0.94 | ||||
EWTX | Edgewise Therapeutics | 0.08 | ||||
SNDX | Syndax Pharmaceuticals | 0.07 | ||||
CCCC | C4 Therapeutics | 0.52 | ||||
GPCR | Structure Therapeutics | 0.52 | ||||
IKNA | Ikena Oncology | 0.62 | ||||
INZY | Inozyme Pharma | 0.71 | ||||
NVCT | Nuvectis Pharma | 0.96 | ||||
DAWN | Day One | 1.61 | ||||
PTGX | Protagonist Therapeutics | 2.16 | ||||
CGEM | Cullinan Oncology | 3.72 | ||||
STOK | Stoke Therapeutics | 3.76 | ||||
KROS | Keros Therapeutics | 6.00 | ||||
ZNTL | Zentalis Pharmaceuticals | 7.02 | ||||
CNTA | Centessa Pharmaceuticals | 7.04 | ||||
HOWL | Werewolf Therapeutics | 7.10 | ||||
CVKD | Cadrenal Therapeutics, | 7.23 | ||||
GLUE | Monte Rosa | 8.27 | ||||
MLYS | Mineralys Therapeutics, | 13.71 | ||||
DSGN | Design Therapeutics | 14.19 |
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |